Alvogen

Description

Alvogen is not a conventional company, and we don’t intend to become one. We are not afraid to follow an unbeaten path in our efforts to differentiate, provide innovative solutions to our customers and drive our business forward. We have defined an ambitious strategic roadmap to guide us towards our goal to become a top ten global player by 2016 and we will have fun doing it.

Our product pipeline is filled by selections from internal R&D candidates, in-licensed products, fostering strategic partnerships and targeted portfolio acquisitions and consists of a broad range of leading molecules for the treatment of conditions in the fields of oncology, cardiology, respiratory, neurology and gastroenterology.

Our passionate team is committed to continue to grow our business around the world and build a top 10 global generics player.

Fact sheet

Companies nearby